Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy

Yuehui Zhao, Naveen Ramesh, Ping Xu, Emi Sei, Min Hu, Shanshan Bai, Patricia Troncoso, Ana M. Aparicio, Christopher J. Logothetis, Paul G. Corn, Nicholas E. Navin, Amado J. Zurita

Cancer Res (2025) 85 (9): 1680–1695.

https://doi.org/10.1158/0008-5472.CAN-24-1943

Published: 02 May 2025

View articletitled, Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy

Includes: Supplementary data

Journal Articles

Abstract 3123: Fracturing the tumor-bone alliance in metastatic prostate cancer with Ra-223

Cancer Res (2025) 85 (8_Supplement_1): 3123.

https://doi.org/10.1158/1538-7445.AM2025-3123

Published: 21 April 2025

View articletitled, Abstract 3123: Fracturing the tumor-bone alliance in metastatic prostate cancer with Ra-223

Journal Articles

Abstract 4760: KDM4A promotes NEPC progression through regulation of MYC expression

Cancer Res (2023) 83 (7_Supplement): 4760.

https://doi.org/10.1158/1538-7445.AM2023-4760

Published: 04 April 2023

View articletitled, Abstract 4760: KDM4A promotes NEPC progression through regulation of MYC expression

Journal Articles

Abstract 3791: Investigating longitudinal therapeutic resistance in serially treated metastatic castration resistant prostate cancer by liquid biopsy genome sequencing

Yuehui Zhao, Naveen Ramesh, Emi Sei, Min Hu, Shanshan Bai, Patricia Troncoso, Paul Corn, Ana Aparicio, Christopher J. Logothetis, Nicholas E. Navin, Amado J. Zurita

Cancer Res (2022) 82 (12_Supplement): 3791.

https://doi.org/10.1158/1538-7445.AM2022-3791

Published: 15 June 2022

View articletitled, Abstract 3791: Investigating longitudinal therapeutic resistance in serially treated metastatic castration resistant prostate cancer by liquid biopsy genome sequencing

Journal Articles

An In Vivo Screen Identifies PYGO2 as a Driver for Metastatic Prostate Cancer

Cancer Res (2018) 78 (14): 3823–3833.

https://doi.org/10.1158/0008-5472.CAN-17-3564

Published: 15 July 2018

View articletitled, An In Vivo Screen Identifies PYGO2 as a Driver for Metastatic Prostate Cancer

Journal Articles

Abstract 4966: High-definition single cell analysis (HD-SCA) reveals enrichment in androgen receptor (AR) expression in tumor cell clusters in bone marrow and blood of metastatic castration-resistant prostate cancer (mCRPC) patients

Amado J. Zurita, Anders Carlsson, Patricia Troncoso, James Hicks, Christopher J. Logothetis, Peter Kuhn

Cancer Res (2016) 76 (14_Supplement): 4966.

https://doi.org/10.1158/1538-7445.AM2016-4966

Published: 15 July 2016

View articletitled, Abstract 4966: High-definition single cell analysis (HD-SCA) reveals enrichment in androgen receptor (AR) expression in tumor cell clusters in bone marrow and blood of metastatic castration-resistant prostate cancer (mCRPC) patients

Journal Articles

Abstract A2: A Study of the effects of MDV3100 in the tumor microenvironment of bone metastatic castrate resistant prostate cancer (bmCRPC)

Eleni Efstathiou, Patricia Troncoso, James Mohler, Christopher J. Logothetis, Mark Titus, Dimitra Tsavachidou, Sijin Wen, Anh Hoang, Robynne Ashe, Maria Karlou, Craig Berman

Cancer Res (2012) 72 (4_Supplement): A2.

https://doi.org/10.1158/1538-7445.PRCA2012-A2

Published: 09 May 2013

View articletitled, Abstract A2: A Study of the effects of MDV3100 in the tumor microenvironment of bone metastatic castrate resistant prostate cancer (bmCRPC)

Journal Articles

Abstract 1195: A molecular characterization of the anaplastic prostate carcinomas.

Ana M. Aparicio, Sankar Maity, Xuemei Wang, Anh G. Hoang, Eleni Efstathiou, Patricia Troncoso, Christopher J. Logothetis

Cancer Res (2013) 73 (8_Supplement): 1195.

https://doi.org/10.1158/1538-7445.AM2013-1195

Published: 15 April 2013

View articletitled, Abstract 1195: A molecular characterization of the anaplastic prostate carcinomas.

Journal Articles

Abstract 2780: Xenografts of human prostate cancer - a genetic profile analysis.

Nallasivam Palanisamy, Jun Yang, Xinhai Wan, John C. Araujo, Eleni Efstathiou, Louis Pisters, Ritu Bhalla, Scott Tomlins, Lakshmi P. Kunju, Arul Chinnaiyan, Christopher J. Logothetis, Patricia Troncoso, Nora M. Navone

Cancer Res (2013) 73 (8_Supplement): 2780.

https://doi.org/10.1158/1538-7445.AM2013-2780

Published: 15 April 2013

View articletitled, Abstract 2780: Xenografts of human prostate cancer - a genetic profile analysis.

Journal Articles

Abstract LB-195: A double-blind randomized controlled multisite trial evaluating tissue effects of preoperative finasteride in clinically organ-confined prostate cancer: Pathologic outcomes.

Cancer Res (2013) 73 (8_Supplement): LB-195.

https://doi.org/10.1158/1538-7445.AM2013-LB-195

Published: 15 April 2013

View articletitled, Abstract LB-195: A double-blind randomized controlled multisite trial evaluating tissue effects of preoperative finasteride in clinically organ-confined prostate cancer: Pathologic outcomes.

Journal Articles

Abstract 2436: Fibroblast growth factor receptor blockade in prostate cancer bone metastases.

Xinhai Wan, Paul Corn, Jun Yang, Eleni Efstathiou, Elsa M. Li Ning Tapia, Fen Wang, Wallace McKeehan, Christopher Logothetis, Patricia Troncoso, Nora M. Navone

Cancer Res (2013) 73 (8_Supplement): 2436.

https://doi.org/10.1158/1538-7445.AM2013-2436

Published: 15 April 2013

View articletitled, Abstract 2436: Fibroblast growth factor receptor blockade in prostate cancer bone metastases.

Journal Articles

Abstract 4388: Combination therapy with anti-CTLA-4 plus leuprolide acetate in the pre-surgical setting of patients with regional, high-risk prostate cancer

Jianjun Gao, Jingjing Sun, John F. Ward, Priya Rao, Patricia Troncoso, John C. Araujo, Derek N. Tang, Hong Chen, Peter Thall, Sijin Wen, Padmanee Sharma

Cancer Res (2012) 72 (8_Supplement): 4388.

https://doi.org/10.1158/1538-7445.AM2012-4388

Published: 15 April 2012

View articletitled, Abstract 4388: Combination therapy with anti-CTLA-4 plus leuprolide acetate in the pre-surgical setting of patients with regional, high-risk prostate cancer

Journal Articles

Abstract 991: The DNA methylome of castration-resistant prostate cancer

Brittney N. Kleb, Marcos Estecio, Jiexin Zhang, Vasso Tzelepi, Woonbok Chung, Sankar Maity, Christopher Logothetis, Patricia Troncoso, Nora Navone, Jaroslav Jelinek, Shoudan Liang, Jean-Pierre Issa, Ana Aparicio

Cancer Res (2012) 72 (8_Supplement): 991.

https://doi.org/10.1158/1538-7445.AM2012-991

Published: 15 April 2012

View articletitled, Abstract 991: The DNA methylome of castration-resistant prostate cancer

Journal Articles

Abstract 2696: Modulation of intracrine androgen signaling in bone metastatic castrate resistant prostate cancer (bmCRPC) by MDV3100

Eleni Efstathiou, Mark Titus, Dimitra Tsavachidou, Sijin Wen, Anh Hoang, Robynne Ashe, Maria Karlou, Craig Berman, Patricia Troncoso, James Mohler, Christopher J. Logothetis

Cancer Res (2012) 72 (8_Supplement): 2696.

https://doi.org/10.1158/1538-7445.AM2012-2696

Published: 15 April 2012

View articletitled, Abstract 2696: Modulation of intracrine androgen signaling in bone metastatic castrate resistant prostate cancer (bmCRPC) by MDV3100

Journal Articles

GLIPR1 Suppresses Prostate Cancer Development through Targeted Oncoprotein Destruction

Likun Li, Chengzhen Ren, Guang Yang, Elmoataz Abdel Fattah, Alexei A. Goltsov, Soo Mi Kim, Ju-Seog Lee, Sanghee Park, Francesco J. Demayo, Michael M. Ittmann, Patricia Troncoso, Timothy C. Thompson

Cancer Res (2011) 71 (24): 7694–7704.

https://doi.org/10.1158/0008-5472.CAN-11-1714

Published: 15 December 2011

View articletitled, GLIPR1 Suppresses Prostate Cancer Development through Targeted Oncoprotein Destruction

Includes: Supplementary data

Journal Articles

Abstract LB-421: Characterization of castrate resistant prostate cancer treated with abiraterone acetate and prednisone

Eleni Efstathiou, Mark Titus, Dimitra Tsavachidou, Vassiliki Tzelepi, Sijin Wen, Anh Hoang, Arturo Molina, Nicole Chieffo, Lisa A. Smith, BS RN Smith, Maria Karlou Karlou, Patricia Troncoso, Christopher J. Logothetis

Cancer Res (2011) 71 (8_Supplement): LB-421.

https://doi.org/10.1158/1538-7445.AM2011-LB-421

Published: 15 April 2011

View articletitled, Abstract LB-421: Characterization of castrate resistant prostate cancer treated with abiraterone acetate and prednisone

Journal Articles

Abstract 36: Molecular profiling of prostate cancer xenografts and human specimens reveals overexpression of UBE2C/UBCH10 and activation of aurora kinases in poorly differentiated neuroendocrine carcinoma of the prostate

Vassiliki Tzelepi, Sankar Maity, Jiexin Zhang, Shoudan Liang, Jing-Fang Lu, Anh Hoang, Brittany Kleb, Eleni Efstathiou, Nora Navone, Patricia Troncoso, Christopher Logothetis, Ana Aparicio

Cancer Res (2011) 71 (8_Supplement): 36.

https://doi.org/10.1158/1538-7445.AM2011-36

Published: 15 April 2011

View articletitled, Abstract 36: Molecular profiling of prostate cancer xenografts and human specimens reveals overexpression of UBE2C/UBCH10 and activation of aurora kinases in poorly differentiated neuroendocrine carcinoma of the prostate

Journal Articles

Abstract #5665: Assessing immunologic impact of anti-CTLA-4 therapy on a pre-surgical clinical trial

Padmanee Sharma, Ashish Kamat, Derek Ng Tang, Hong Chen, Tihui Fu, Jingjing Sun, Patricia Troncoso, Jianda Yuan, Jedd Wolchok, Sergio Quezada, Christopher Logothetis, James Allison

Cancer Res (2009) 69 (9_Supplement): 5665.

Published: 01 May 2009

View articletitled, Abstract #5665: Assessing immunologic impact of anti-CTLA-4 therapy on a pre-surgical clinical trial

Journal Articles

Androgen receptor-negative human prostate cancer cells induce osteogenesis through FGF9-mediated mechanisms

Zhi-Gang Li, Nora Navone, Jun Yang, Jie Liu, Paul Mathew, Michael Starbuck, Amado Zurita, Charles Sikes, Asha Multani, Eleni Efstathiou, Adriana Lopez, Jing Wang, Tina Fanning, Victor Prieto, Vikas Kundra, Patricia Troncoso, Austin Raymond, Sue-Hwa Lin, Elba Vazquez

Cancer Res (2008) 68 (9_Supplement): 1612.

Published: 01 May 2008

View articletitled, Androgen receptor-negative human prostate cancer cells induce osteogenesis through FGF9-mediated mechanisms

Journal Articles

The ratio of matrix metalloproteinase to E-cadherin expression level: Prognostic significance of mRNA and protein expression among African American prostate cancer patients

Curtis A. Pettaway, Renduo Song, Xuemei Wang, Kim-Anh Do, Sara Strom, Patricia Troncoso

Cancer Res (2005) 65 (9_Supplement): 745.

Published: 01 May 2005

View articletitled, The ratio of matrix metalloproteinase to E-cadherin expression level: Prognostic significance of mRNA and protein expression among African American prostate cancer patients

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy

Abstract 3123: Fracturing the tumor-bone alliance in metastatic prostate cancer with Ra-223

Abstract 4760: KDM4A promotes NEPC progression through regulation of MYC expression

Abstract 3791: Investigating longitudinal therapeutic resistance in serially treated metastatic castration resistant prostate cancer by liquid biopsy genome sequencing

An In Vivo Screen Identifies PYGO2 as a Driver for Metastatic Prostate Cancer

Abstract 4966: High-definition single cell analysis (HD-SCA) reveals enrichment in androgen receptor (AR) expression in tumor cell clusters in bone marrow and blood of metastatic castration-resistant prostate cancer (mCRPC) patients

Abstract A2: A Study of the effects of MDV3100 in the tumor microenvironment of bone metastatic castrate resistant prostate cancer (bmCRPC)

Abstract 1195: A molecular characterization of the anaplastic prostate carcinomas.

Abstract 2780: Xenografts of human prostate cancer - a genetic profile analysis.

Abstract LB-195: A double-blind randomized controlled multisite trial evaluating tissue effects of preoperative finasteride in clinically organ-confined prostate cancer: Pathologic outcomes.

Abstract 2436: Fibroblast growth factor receptor blockade in prostate cancer bone metastases.

Abstract 4388: Combination therapy with anti-CTLA-4 plus leuprolide acetate in the pre-surgical setting of patients with regional, high-risk prostate cancer

Abstract 991: The DNA methylome of castration-resistant prostate cancer

Abstract 2696: Modulation of intracrine androgen signaling in bone metastatic castrate resistant prostate cancer (bmCRPC) by MDV3100

GLIPR1 Suppresses Prostate Cancer Development through Targeted Oncoprotein Destruction

Abstract LB-421: Characterization of castrate resistant prostate cancer treated with abiraterone acetate and prednisone

Abstract 36: Molecular profiling of prostate cancer xenografts and human specimens reveals overexpression of UBE2C/UBCH10 and activation of aurora kinases in poorly differentiated neuroendocrine carcinoma of the prostate

Abstract #5665: Assessing immunologic impact of anti-CTLA-4 therapy on a pre-surgical clinical trial

Androgen receptor-negative human prostate cancer cells induce osteogenesis through FGF9-mediated mechanisms

The ratio of matrix metalloproteinase to E-cadherin expression level: Prognostic significance of mRNA and protein expression among African American prostate cancer patients

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only